Clinical trial
Role of SGLT2I in Diabetic Patients With Myocardial Infarction
NCT06245980 is registered in ClinicalTrials.gov with Dongying Zhang as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Role of SGLT2I in Diabetic Patients With Myocardial Infarction
- Lead sponsor
- Dongying Zhang
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- January 1, 2018
- Completion date
- March 31, 2024
- Enrollment
- 1,200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.